Back

COMPASS Trial - Bleeding and cancer risk in patients with vascular disease treated with Rivaroxaban

26 August 2018 (11:00 - 11:10)
Organised by:
Congress Presentation Part of: Clinical Trial Updates Secondary Prevention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor John William Eikelboom

McMaster University, Hamilton (Canada)

11 More presentations in this session

Presentation thumbnail
Discussant review - COMPASS.
Professor L. Wallentin (Uppsala, SE)
Slides Video
Presentation thumbnail
CANTOS - Modulation of the Interleukin-6 Signaling Pathway and Incidence Rates of Atherosclerotic Events and Mortality
Doctor P. Ridker (Boston, US)
Slides Video
Presentation thumbnail
Discussant review - CANTOS.
Professor M. Packer (Dallas, US)
Slides Video
Presentation thumbnail
CABANA Trial - Recurrence of Atrial Arrhythmias in the Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation
Professor J. Poole (Seattle, US)
Slides Video
Presentation thumbnail
Discussant review - CABANA.
Professor C. Leclercq (Rennes, FR)
Slides Video

Access the full session

Session thumbnail
Clinical Trial Updates

The Event

Event poster

ESC Congress 2018

26 August 2018 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Secondary prevention after one-year of a cardiovascular rehabilitation program: a single-centre analysis
thumbnail
Congress Presentation
Secondary prevention in young patients after acute ST segment elevation myocardial infarction: missing the goals and suffering the penalties
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources